Position in CELC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,334,068
+$883,044 QoQ
Shares Held
11,688
+158.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INTEGRITY ALLIANCE, LLC. holds $3,721,546 across 8 Biotechnology names. CELC ranks #2 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
9,585 | $1,620,056 | |
| 2 | CELC |
Celcuity Inc.
This page
|
11,688 | $1,334,068 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
489 | $377,820 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
588 | $262,565 | |
| 5 | GNLX |
GENELUX Corp
|
15,052 | $36,425 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
11,400 | $34,998 | |
| 7 | HUMA |
Humacyte, Inc.
|
57,300 | $34,781 | |
| 8 | CRDF |
Cardiff Oncology, Inc.
|
12,860 | $20,833 |
All Filings in CELC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,334,068 | 11,688 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $451,024 | 4,522 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||